Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Steven Rosenberg

Concepts (599)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
57
2025
328
13.590
 Why?
Lymphocytes, Tumor-Infiltrating
63
2026
219
13.510
 Why?
Receptors, Antigen, T-Cell
55
2024
726
10.640
 Why?
Immunotherapy, Adoptive
54
2026
381
9.950
 Why?
T-Lymphocytes
48
2026
2041
7.120
 Why?
Melanoma
50
2026
806
7.030
 Why?
Neoplasms
35
2025
2902
4.980
 Why?
Gastrointestinal Neoplasms
8
2025
77
4.330
 Why?
CD8-Positive T-Lymphocytes
26
2023
945
3.690
 Why?
Autism Spectrum Disorder
22
2024
431
3.340
 Why?
Immunotherapy
16
2025
669
3.010
 Why?
Adoptive Transfer
18
2024
219
2.650
 Why?
Proto-Oncogene Proteins p21(ras)
8
2022
267
2.570
 Why?
Developmental Disabilities
13
2023
294
2.320
 Why?
Mutation
32
2025
4106
2.300
 Why?
Cancer Vaccines
8
2021
167
2.040
 Why?
Antigens, CD19
10
2026
139
2.010
 Why?
Programmed Cell Death 1 Receptor
9
2025
270
1.850
 Why?
CD4-Positive T-Lymphocytes
12
2022
1133
1.830
 Why?
Interleukin-2
7
2025
447
1.770
 Why?
Skin Neoplasms
13
2020
860
1.770
 Why?
Neoplasm Metastasis
18
2024
704
1.710
 Why?
Autistic Disorder
8
2024
214
1.650
 Why?
Humans
196
2026
143817
1.450
 Why?
ras Proteins
4
2021
155
1.380
 Why?
Colorectal Neoplasms
5
2025
848
1.300
 Why?
Neoplasm Proteins
7
2019
443
1.280
 Why?
Tumor Suppressor Protein p53
6
2022
541
1.230
 Why?
High-Throughput Nucleotide Sequencing
6
2025
559
1.200
 Why?
Epitopes, T-Lymphocyte
9
2021
185
1.160
 Why?
Eligibility Determination
3
2014
69
1.150
 Why?
Genetic Therapy
8
2022
322
1.100
 Why?
Lymphoma, B-Cell
4
2020
136
1.040
 Why?
Membrane Proteins
9
2019
1182
1.030
 Why?
Female
103
2026
77569
1.010
 Why?
Glioblastoma
2
2021
350
0.980
 Why?
Proto-Oncogene Proteins B-raf
4
2019
230
0.980
 Why?
Motor Skills Disorders
4
2016
29
0.960
 Why?
Child Development
7
2024
494
0.900
 Why?
Male
88
2026
71568
0.880
 Why?
Genetic Engineering
6
2016
98
0.850
 Why?
Middle Aged
57
2026
35629
0.850
 Why?
Transcriptome
4
2022
1047
0.840
 Why?
HLA-A2 Antigen
11
2020
47
0.840
 Why?
Gene Expression Regulation, Neoplastic
7
2019
1496
0.800
 Why?
Cell Line, Tumor
26
2021
3609
0.790
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2017
193
0.790
 Why?
Coronary Artery Disease
6
2017
726
0.780
 Why?
Hematopoietic Stem Cell Transplantation
4
2026
681
0.780
 Why?
Flow Cytometry
9
2018
1192
0.770
 Why?
Precision Medicine
3
2015
450
0.760
 Why?
T-Lymphocyte Subsets
5
2019
421
0.750
 Why?
Ovarian Neoplasms
2
2019
594
0.730
 Why?
Medicare Part C
2
2013
33
0.730
 Why?
Tumor Microenvironment
2
2019
738
0.720
 Why?
Cell Separation
4
2019
311
0.710
 Why?
Adult
47
2026
40128
0.690
 Why?
HLA-DP beta-Chains
3
2019
90
0.680
 Why?
Single-Cell Analysis
3
2022
360
0.670
 Why?
Interleukin-12
3
2020
121
0.670
 Why?
Receptors, Antigen
3
2015
17
0.660
 Why?
Aged
36
2026
25616
0.630
 Why?
HLA-A Antigens
2
2021
54
0.630
 Why?
Receptors, Antigen, T-Cell, alpha-beta
4
2020
335
0.630
 Why?
Cognition Disorders
2
2016
542
0.620
 Why?
Antigen Presentation
8
2020
215
0.620
 Why?
Retroviridae
2
2022
103
0.610
 Why?
Mutation, Missense
2
2020
342
0.600
 Why?
Interleukin-15
2
2017
99
0.600
 Why?
Colonic Neoplasms
2
2019
262
0.590
 Why?
Mucin-4
1
2019
4
0.590
 Why?
Smad5 Protein
1
2019
8
0.590
 Why?
Temperament
1
2019
39
0.590
 Why?
Lymphocyte Depletion
2
2016
135
0.580
 Why?
Exome
7
2016
239
0.580
 Why?
Immunity, Cellular
1
2020
273
0.580
 Why?
T-Lymphocytes, Regulatory
2
2019
392
0.570
 Why?
Child, Preschool
29
2024
11631
0.560
 Why?
Cholangiocarcinoma
2
2023
105
0.560
 Why?
Sequence Analysis, DNA
2
2021
828
0.550
 Why?
Bile Duct Neoplasms
2
2023
127
0.550
 Why?
ErbB Receptors
2
2019
626
0.550
 Why?
Disease Susceptibility
1
2019
351
0.520
 Why?
Genetic Vectors
5
2022
342
0.510
 Why?
Family Characteristics
2
2018
199
0.510
 Why?
Antigens
1
2019
349
0.510
 Why?
History, 20th Century
4
2025
327
0.500
 Why?
Child Behavior
1
2019
239
0.500
 Why?
RNA, Messenger
3
2020
2847
0.500
 Why?
Social Behavior
2
2023
289
0.500
 Why?
Immunologic Memory
6
2026
375
0.490
 Why?
History, 21st Century
3
2025
222
0.490
 Why?
Awards and Prizes
1
2017
70
0.480
 Why?
Myocardial Perfusion Imaging
2
2013
49
0.480
 Why?
Transposases
1
2016
18
0.480
 Why?
Cell Engineering
1
2016
15
0.470
 Why?
Communication
2
2023
959
0.460
 Why?
Gene Expression Profiling
8
2019
1817
0.460
 Why?
Bile Ducts, Intrahepatic
2
2023
63
0.460
 Why?
Self-Injurious Behavior
4
2018
136
0.460
 Why?
Cell Cycle Checkpoints
1
2016
107
0.450
 Why?
Lymphoma
1
2017
234
0.450
 Why?
Psychotherapy
1
2017
186
0.450
 Why?
Surveys and Questionnaires
9
2024
6004
0.420
 Why?
T-Cell Antigen Receptor Specificity
7
2020
52
0.410
 Why?
Lymphocyte Transfusion
1
2013
21
0.410
 Why?
Lymphocyte Activation
10
2020
1143
0.400
 Why?
Lymphocytes
1
2016
395
0.400
 Why?
Sentinel Lymph Node Biopsy
1
2014
120
0.400
 Why?
Th1 Cells
1
2014
142
0.400
 Why?
Vidarabine
4
2017
36
0.400
 Why?
Breast Neoplasms
3
2022
2497
0.390
 Why?
Metastasectomy
3
2026
22
0.390
 Why?
Plaque, Atherosclerotic
1
2014
60
0.390
 Why?
Leukemia
2
2016
246
0.390
 Why?
Histocompatibility Antigens Class I
5
2021
208
0.380
 Why?
Lymph Node Excision
1
2014
173
0.380
 Why?
Transplantation Conditioning
4
2019
189
0.380
 Why?
Animals
29
2024
38140
0.380
 Why?
Indoles
1
2016
479
0.380
 Why?
Child
22
2024
22441
0.380
 Why?
Neoplasms, Glandular and Epithelial
2
2026
51
0.380
 Why?
Cyclophosphamide
4
2017
267
0.380
 Why?
Sulfonamides
1
2016
574
0.370
 Why?
Melanoma, Experimental
4
2020
112
0.370
 Why?
Cell- and Tissue-Based Therapy
3
2019
83
0.370
 Why?
Stem Cell Transplantation
1
2013
190
0.370
 Why?
Transfection
1
2014
952
0.360
 Why?
Gene Expression
7
2016
1512
0.350
 Why?
Genes, T-Cell Receptor
3
2022
9
0.350
 Why?
Mice
21
2024
18421
0.350
 Why?
Melanoma-Specific Antigens
3
2016
5
0.340
 Why?
Adaptor Proteins, Signal Transducing
1
2014
439
0.340
 Why?
Antibodies, Monoclonal
3
2017
1522
0.330
 Why?
Neoplasms, Second Primary
2
2022
102
0.330
 Why?
Coronary Angiography
5
2017
312
0.330
 Why?
Biomarkers, Tumor
6
2019
1327
0.330
 Why?
Case-Control Studies
13
2024
3614
0.320
 Why?
Coculture Techniques
3
2021
250
0.320
 Why?
Treatment Outcome
15
2021
11459
0.320
 Why?
Lung Neoplasms
3
2022
2636
0.320
 Why?
Transplantation, Autologous
3
2022
290
0.320
 Why?
United States
16
2025
15602
0.310
 Why?
Papillomaviridae
3
2019
121
0.310
 Why?
gp100 Melanoma Antigen
5
2016
8
0.310
 Why?
Medicaid
1
2014
455
0.310
 Why?
Child Development Disorders, Pervasive
2
2024
64
0.310
 Why?
Kidney Neoplasms
1
2014
410
0.310
 Why?
Papillomavirus Infections
3
2018
354
0.300
 Why?
Infant
11
2017
9886
0.300
 Why?
Transduction, Genetic
4
2019
136
0.290
 Why?
Combined Modality Therapy
5
2021
1261
0.280
 Why?
Human papillomavirus 16
3
2018
31
0.280
 Why?
Peptides
4
2020
986
0.280
 Why?
Phenotype
6
2024
3182
0.280
 Why?
Repressor Proteins
3
2017
432
0.270
 Why?
Prospective Studies
8
2023
7900
0.270
 Why?
Intellectual Disability
3
2024
176
0.270
 Why?
Antigens, Differentiation, T-Lymphocyte
2
2020
102
0.270
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
3
2017
26
0.260
 Why?
Cells, Cultured
8
2021
4172
0.260
 Why?
Carcinoma, Squamous Cell
3
2017
646
0.250
 Why?
Prevalence
8
2018
2819
0.250
 Why?
Algorithms
3
2015
1843
0.250
 Why?
Dendritic Cells
4
2019
495
0.250
 Why?
Neoplasm Staging
5
2018
1453
0.250
 Why?
Oncogene Proteins, Viral
2
2017
22
0.250
 Why?
Lymphocyte Count
2
2016
168
0.240
 Why?
Cell Proliferation
8
2019
2540
0.240
 Why?
Tomography, X-Ray Computed
6
2018
2782
0.240
 Why?
Uterine Cervical Neoplasms
4
2018
275
0.240
 Why?
CD8 Antigens
2
2018
74
0.240
 Why?
Young Adult
13
2020
13914
0.240
 Why?
Antigens, CD
3
2020
564
0.230
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2014
1938
0.230
 Why?
Carcinoma
2
2018
230
0.230
 Why?
National Cancer Institute (U.S.)
1
2025
52
0.220
 Why?
Tumor Cells, Cultured
5
2018
944
0.220
 Why?
Whole-Body Irradiation
2
2016
78
0.220
 Why?
Pilot Projects
5
2019
1851
0.220
 Why?
Brain Neoplasms
4
2018
1307
0.220
 Why?
Socioeconomic Factors
3
2018
1327
0.220
 Why?
DNA Transposable Elements
2
2016
121
0.210
 Why?
Longitudinal Studies
5
2016
2947
0.210
 Why?
T-Lymphocytes, Cytotoxic
2
2015
178
0.210
 Why?
Jaundice, Neonatal
1
2023
9
0.210
 Why?
Sensitivity and Specificity
3
2018
1984
0.210
 Why?
Adolescent
13
2023
22233
0.200
 Why?
Immunohistochemistry
4
2016
1733
0.200
 Why?
Hepatectomy
1
2026
268
0.200
 Why?
Disability Evaluation
3
2014
306
0.200
 Why?
Leukocytes, Mononuclear
3
2015
580
0.200
 Why?
Infant, Very Low Birth Weight
2
2014
75
0.200
 Why?
Protein Engineering
2
2014
119
0.190
 Why?
Problem Behavior
2
2022
104
0.190
 Why?
Proto-Oncogene Proteins
2
2017
628
0.190
 Why?
Parks, Recreational
1
2022
12
0.190
 Why?
Constriction, Pathologic
2
2014
246
0.190
 Why?
Follow-Up Studies
8
2026
5317
0.180
 Why?
DNA-Binding Proteins
3
2019
1493
0.180
 Why?
Time-to-Treatment
1
2024
235
0.180
 Why?
HEK293 Cells
5
2017
748
0.180
 Why?
Proteasome Endopeptidase Complex
2
2020
162
0.180
 Why?
Burkitt Lymphoma
1
2022
63
0.180
 Why?
Amino Acid Sequence
4
2020
2148
0.180
 Why?
Occupational Therapy
2
2014
112
0.180
 Why?
Clone Cells
2
2019
269
0.180
 Why?
Stem Cells
1
2026
622
0.170
 Why?
Sex Factors
4
2017
2078
0.170
 Why?
Oncogenes
2
2020
121
0.170
 Why?
Prognosis
7
2026
4211
0.170
 Why?
Biomarkers
3
2019
4248
0.170
 Why?
Exercise Test
2
2015
621
0.170
 Why?
Adaptation, Psychological
2
2024
705
0.170
 Why?
Genes, Tumor Suppressor
2
2019
90
0.170
 Why?
Genes, T-Cell Receptor alpha
1
2021
12
0.170
 Why?
Liver Neoplasms
2
2026
774
0.170
 Why?
Demography
3
2018
289
0.170
 Why?
Gene Expression Regulation
3
2019
2620
0.170
 Why?
Apyrase
1
2020
27
0.170
 Why?
Cytokines
6
2022
2093
0.170
 Why?
Lectins, C-Type
1
2020
63
0.170
 Why?
HLA Antigens
2
2021
227
0.170
 Why?
Epitope Mapping
2
2018
65
0.160
 Why?
Oncolytic Virotherapy
1
2020
14
0.160
 Why?
MART-1 Antigen
3
2014
11
0.160
 Why?
Pancreatic Neoplasms
2
2022
927
0.160
 Why?
Psychotropic Drugs
1
2021
76
0.160
 Why?
Mice, Mutant Strains
1
2020
306
0.160
 Why?
Multiple Myeloma
1
2023
292
0.160
 Why?
Models, Immunological
1
2020
100
0.160
 Why?
Lymphatic Metastasis
2
2019
333
0.160
 Why?
Physical Therapy Modalities
2
2014
328
0.160
 Why?
Drug Utilization
1
2021
163
0.160
 Why?
HLA-C Antigens
2
2020
38
0.160
 Why?
Protein Binding
8
2020
2261
0.150
 Why?
Remission Induction
5
2020
307
0.150
 Why?
Premature Birth
1
2023
377
0.150
 Why?
Amino Acid Substitution
1
2020
304
0.150
 Why?
Virus Replication
1
2022
537
0.150
 Why?
Age Factors
3
2024
3288
0.150
 Why?
Gene Regulatory Networks
1
2022
322
0.150
 Why?
Genes, Neoplasm
1
2019
26
0.150
 Why?
Cysteine
1
2020
210
0.150
 Why?
Neoplasm Recurrence, Local
2
2017
1123
0.140
 Why?
Alcohol Oxidoreductases
1
2019
63
0.140
 Why?
Antibodies, Monoclonal, Humanized
1
2025
982
0.140
 Why?
Practice Patterns, Physicians'
2
2021
1322
0.140
 Why?
Gestational Age
2
2024
974
0.140
 Why?
Area Under Curve
3
2014
333
0.140
 Why?
Cell Line
4
2022
2906
0.140
 Why?
Trees
1
2018
68
0.140
 Why?
Neoplastic Cells, Circulating
1
2019
82
0.140
 Why?
B-Lymphocytes
3
2020
889
0.140
 Why?
RGS Proteins
1
2018
18
0.140
 Why?
Smoking
2
2018
1556
0.140
 Why?
Cohort Studies
6
2016
5862
0.140
 Why?
Referral and Consultation
4
2023
839
0.140
 Why?
Ubiquitin Thiolesterase
1
2018
59
0.140
 Why?
Behavior Therapy
1
2021
286
0.140
 Why?
Forkhead Transcription Factors
1
2019
205
0.140
 Why?
Education, Special
1
2017
24
0.140
 Why?
Mothers
1
2024
769
0.130
 Why?
Medical Oncology
1
2020
327
0.130
 Why?
Survival Rate
5
2026
2035
0.130
 Why?
Parents
4
2022
1414
0.130
 Why?
Psychometrics
2
2019
728
0.130
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 14
1
2017
3
0.130
 Why?
Self-Examination
1
2017
2
0.130
 Why?
Uveal Neoplasms
1
2017
14
0.130
 Why?
Hematologic Neoplasms
1
2019
162
0.130
 Why?
Recombinant Fusion Proteins
3
2015
683
0.130
 Why?
Lymphoma, Non-Hodgkin
1
2018
124
0.130
 Why?
Societies, Scientific
1
2017
51
0.130
 Why?
Maternal Age
1
2017
127
0.130
 Why?
Interferon-gamma
5
2020
791
0.130
 Why?
Immunologic Surveillance
1
2017
26
0.130
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2017
178
0.130
 Why?
Signal Transduction
5
2019
5241
0.130
 Why?
ROC Curve
3
2013
607
0.130
 Why?
Administration, Intravenous
1
2017
170
0.120
 Why?
Population Surveillance
2
2017
491
0.120
 Why?
fas Receptor
2
2015
94
0.120
 Why?
Carcinogenesis
1
2018
231
0.120
 Why?
Tissue and Organ Procurement
1
2020
336
0.120
 Why?
Sialadenitis
1
2016
2
0.120
 Why?
Disease Progression
5
2017
2871
0.120
 Why?
CTLA-4 Antigen
1
2017
107
0.120
 Why?
Mitogen-Activated Protein Kinases
1
2017
298
0.120
 Why?
WT1 Proteins
1
2016
13
0.120
 Why?
Peptidomimetics
1
2016
4
0.120
 Why?
Logistic Models
4
2016
2095
0.120
 Why?
Green Fluorescent Proteins
2
2015
405
0.120
 Why?
HLA-DQ beta-Chains
1
2016
59
0.120
 Why?
Urinary Bladder Neoplasms
1
2019
252
0.120
 Why?
Circulating Tumor DNA
1
2016
44
0.120
 Why?
Immunoglobulin M
1
2017
287
0.120
 Why?
Antineoplastic Agents
2
2017
2220
0.120
 Why?
ras GTPase-Activating Proteins
1
2015
15
0.120
 Why?
Immunoglobulin A
1
2017
218
0.120
 Why?
Transplantation Chimera
1
2016
57
0.120
 Why?
Immunodominant Epitopes
1
2015
28
0.120
 Why?
Clonal Evolution
1
2016
48
0.120
 Why?
Coronary Vessels
2
2017
250
0.120
 Why?
Proto-Oncogene Proteins c-akt
2
2015
442
0.120
 Why?
Peer Group
1
2018
250
0.120
 Why?
Psychoanalytic Therapy
1
1995
14
0.120
 Why?
Molecular Targeted Therapy
1
2019
440
0.120
 Why?
T-Lymphocytes, Helper-Inducer
1
2016
135
0.120
 Why?
Receptors, HIV
1
2015
24
0.110
 Why?
RNA, Neoplasm
1
2015
90
0.110
 Why?
Epitopes
2
2015
490
0.110
 Why?
Cesarean Section
1
2017
224
0.110
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
78
0.110
 Why?
Zinc Fingers
1
2015
53
0.110
 Why?
Aged, 80 and over
3
2025
8130
0.110
 Why?
Alphapapillomavirus
1
2015
36
0.110
 Why?
Psychotherapy, Brief
1
1995
41
0.110
 Why?
Odds Ratio
2
2014
1057
0.110
 Why?
Immunophenotyping
1
2016
327
0.110
 Why?
Sarcoma, Synovial
1
2014
22
0.110
 Why?
Neoplasms, Germ Cell and Embryonal
1
2016
76
0.110
 Why?
Immunity, Active
1
2014
9
0.110
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2014
10
0.110
 Why?
Psychotherapy, Group
1
1995
74
0.110
 Why?
Endoribonucleases
1
2015
80
0.110
 Why?
Language
1
2018
322
0.110
 Why?
Managed Care Programs
1
1995
135
0.110
 Why?
Metalloproteins
1
2014
5
0.110
 Why?
Aspirin
1
2018
389
0.110
 Why?
Clinical Trials as Topic
5
2020
1047
0.110
 Why?
Clinical Trials, Phase II as Topic
1
2014
78
0.100
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2014
30
0.100
 Why?
5' Untranslated Regions
1
2014
60
0.100
 Why?
Nitric Oxide Synthase Type I
1
2014
31
0.100
 Why?
Triple Negative Breast Neoplasms
1
2017
220
0.100
 Why?
Thrombotic Microangiopathies
1
2014
20
0.100
 Why?
Echocardiography, Stress
1
2013
25
0.100
 Why?
Ribosomal Proteins
1
2014
93
0.100
 Why?
Tumor Lysis Syndrome
1
2013
8
0.100
 Why?
MAP Kinase Kinase Kinase 5
1
2013
7
0.100
 Why?
Transcription Factors
2
2019
1735
0.100
 Why?
Mice, Transgenic
5
2020
2182
0.100
 Why?
Policy Making
1
2014
82
0.100
 Why?
Autografts
1
2013
51
0.100
 Why?
Thioredoxins
1
2013
32
0.100
 Why?
HLA-DR4 Antigen
1
2013
75
0.100
 Why?
Testis
1
2014
166
0.100
 Why?
Extremities
1
2014
141
0.100
 Why?
Motor Skills
1
2014
105
0.100
 Why?
Health Care Reform
1
2014
108
0.100
 Why?
Psychiatric Status Rating Scales
1
2015
525
0.100
 Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1178
0.100
 Why?
Interferon-alpha
1
2014
184
0.100
 Why?
Cross-Sectional Studies
5
2017
5761
0.100
 Why?
Gene Expression Regulation, Enzymologic
1
2014
273
0.100
 Why?
Immunoglobulin G
1
2017
899
0.100
 Why?
Transcriptional Activation
1
2015
382
0.100
 Why?
Astrocytoma
1
2013
131
0.100
 Why?
Allografts
1
2013
151
0.090
 Why?
Histones
1
2018
655
0.090
 Why?
Cell Movement
4
2019
973
0.090
 Why?
Likelihood Functions
1
2013
140
0.090
 Why?
Radiation Injuries
1
2014
147
0.090
 Why?
Cognition
2
2023
1252
0.090
 Why?
Nuclear Proteins
2
2015
751
0.090
 Why?
Nanotechnology
1
2013
127
0.090
 Why?
Receptors, N-Methyl-D-Aspartate
1
2014
225
0.090
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
238
0.090
 Why?
Infant, Newborn
4
2023
6362
0.090
 Why?
Esophageal Neoplasms
1
2016
347
0.090
 Why?
Risk Factors
5
2023
10623
0.090
 Why?
Calcinosis
1
2014
235
0.090
 Why?
Muscle Proteins
1
2013
247
0.090
 Why?
Sarcoma
1
2014
203
0.090
 Why?
Prostatic Neoplasms
1
2019
977
0.090
 Why?
Cost of Illness
1
2014
320
0.090
 Why?
Risk Assessment
3
2019
3556
0.090
 Why?
Killer Cells, Natural
1
2014
473
0.090
 Why?
Propensity Score
1
2013
359
0.080
 Why?
Research Design
2
2014
1121
0.080
 Why?
Head and Neck Neoplasms
1
2016
560
0.080
 Why?
Genome, Human
1
2013
429
0.080
 Why?
Health Policy
1
2014
390
0.080
 Why?
Anxiety
1
2018
1100
0.080
 Why?
Transplantation, Homologous
2
2026
414
0.080
 Why?
Cytotoxicity, Immunologic
3
2016
226
0.080
 Why?
Randomized Controlled Trials as Topic
2
2013
1688
0.080
 Why?
Xenograft Model Antitumor Assays
3
2020
945
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2014
991
0.080
 Why?
Genetic Testing
1
2013
475
0.080
 Why?
RNA-Binding Proteins
1
2014
466
0.080
 Why?
Wounds and Injuries
1
2018
949
0.080
 Why?
Decision Support Techniques
1
2013
446
0.080
 Why?
Models, Theoretical
1
2013
586
0.070
 Why?
K562 Cells
2
2020
94
0.070
 Why?
Time Factors
2
2017
7068
0.070
 Why?
Real-Time Polymerase Chain Reaction
3
2015
345
0.070
 Why?
HIV-1
1
2015
904
0.070
 Why?
Databases, Factual
3
2023
1459
0.070
 Why?
Colorado
2
2017
4578
0.070
 Why?
Coronary Stenosis
1
2008
38
0.070
 Why?
Adenocarcinoma
1
2016
927
0.070
 Why?
Retrospective Studies
6
2026
16755
0.070
 Why?
Comorbidity
3
2018
1638
0.070
 Why?
Arthritis, Rheumatoid
1
2017
1170
0.070
 Why?
RNA
1
2015
940
0.070
 Why?
Double-Blind Method
1
2013
2017
0.070
 Why?
Protein Kinase Inhibitors
1
2014
1000
0.070
 Why?
Apoptosis
2
2013
2446
0.070
 Why?
Anti-HIV Agents
1
2015
864
0.070
 Why?
Neoplasm Transplantation
3
2015
256
0.060
 Why?
RNA, Small Interfering
3
2014
645
0.060
 Why?
Neutrophils
1
2013
1144
0.060
 Why?
Protective Factors
2
2017
102
0.060
 Why?
Faculty
1
2007
149
0.060
 Why?
DNA Mutational Analysis
2
2019
408
0.060
 Why?
Cross Reactions
2
2016
134
0.060
 Why?
Mass Screening
2
2020
1325
0.060
 Why?
Cardiovascular Diseases
1
2018
2098
0.060
 Why?
Molecular Sequence Data
3
2015
2914
0.060
 Why?
CD4 Antigens
2
2016
144
0.060
 Why?
Neutropenia
2
2017
155
0.060
 Why?
Mice, Inbred NOD
2
2018
615
0.050
 Why?
Mice, Inbred C57BL
4
2020
6032
0.050
 Why?
Single-Chain Antibodies
2
2015
17
0.050
 Why?
Protein Transport
2
2017
445
0.050
 Why?
Intercellular Junctions
2
2014
38
0.050
 Why?
Physical Examination
2
2017
235
0.050
 Why?
Parity
1
2024
110
0.050
 Why?
GPI-Linked Proteins
2
2014
83
0.050
 Why?
Nerve Tissue Proteins
2
2020
600
0.050
 Why?
Lung
1
2016
4143
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2023
29
0.050
 Why?
Point Mutation
2
2014
245
0.050
 Why?
Tissue Donors
1
2026
413
0.050
 Why?
Exercise
1
2015
2196
0.050
 Why?
Health Facilities
1
2023
86
0.050
 Why?
Autoantigens
2
2016
429
0.050
 Why?
Recurrence
1
2026
1122
0.050
 Why?
Bone Marrow
1
2023
303
0.050
 Why?
Minority Groups
1
2024
280
0.050
 Why?
Receptors, Cell Surface
1
2004
380
0.040
 Why?
Cluster Analysis
2
2014
530
0.040
 Why?
Linear Models
1
2024
857
0.040
 Why?
Alleles
2
2015
883
0.040
 Why?
Skin
2
2019
760
0.040
 Why?
Oligonucleotide Array Sequence Analysis
2
2014
765
0.040
 Why?
Educational Status
1
2023
463
0.040
 Why?
Severity of Illness Index
2
2023
2925
0.040
 Why?
Recombinant Proteins
2
2014
1355
0.040
 Why?
Proportional Hazards Models
1
2024
1305
0.040
 Why?
Models, Genetic
2
2013
533
0.040
 Why?
Parenting
1
2024
322
0.040
 Why?
Jurkat Cells
1
2020
118
0.040
 Why?
Base Sequence
2
2014
2186
0.040
 Why?
Immunoglobulins
1
2020
163
0.040
 Why?
Predictive Value of Tests
2
2017
2097
0.040
 Why?
Cysteine Endopeptidases
1
2020
74
0.040
 Why?
Glioma
1
2004
424
0.040
 Why?
Early Diagnosis
1
2020
247
0.040
 Why?
Health Care Surveys
1
2021
535
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2019
89
0.040
 Why?
Hydrolysis
1
2019
199
0.040
 Why?
GTP Phosphohydrolases
1
2019
95
0.040
 Why?
Fusion Regulatory Protein 1, Heavy Chain
1
2018
3
0.040
 Why?
Uterine Cervical Dysplasia
1
2018
30
0.030
 Why?
Forests
1
2018
59
0.030
 Why?
Caregivers
2
2018
1025
0.030
 Why?
GTP-Binding Protein alpha Subunits, Gi-Go
1
2018
20
0.030
 Why?
Protein Domains
1
2020
313
0.030
 Why?
Cervix Uteri
1
2018
52
0.030
 Why?
Nuclear Localization Signals
1
2017
18
0.030
 Why?
Neoplasm Grading
1
2019
309
0.030
 Why?
Mice, SCID
1
2018
377
0.030
 Why?
Disulfides
1
2018
99
0.030
 Why?
Hydrogen Bonding
1
2018
166
0.030
 Why?
Healthcare Disparities
1
2024
700
0.030
 Why?
Ligands
2
2013
674
0.030
 Why?
Platelet Aggregation
1
2018
103
0.030
 Why?
Human papillomavirus 18
1
2017
14
0.030
 Why?
Eye Enucleation
1
2017
15
0.030
 Why?
Response Evaluation Criteria in Solid Tumors
1
2017
23
0.030
 Why?
Protein Stability
1
2018
177
0.030
 Why?
GTP-Binding Protein alpha Subunits
1
2017
16
0.030
 Why?
GTP-Binding Protein alpha Subunits, Gq-G11
1
2017
20
0.030
 Why?
Culture Media, Serum-Free
1
2016
43
0.030
 Why?
Peptide Fragments
2
2015
706
0.030
 Why?
Lymphopenia
1
2017
69
0.030
 Why?
Binding Sites
1
2020
1312
0.030
 Why?
Drug Synergism
1
2017
364
0.030
 Why?
Vaccinia virus
1
2016
44
0.030
 Why?
Antigen-Presenting Cells
1
2017
163
0.030
 Why?
HLA-DRB1 Chains
1
2017
111
0.030
 Why?
Asymptomatic Diseases
1
2017
98
0.030
 Why?
Blood Chemical Analysis
1
2017
110
0.030
 Why?
Salivary Glands, Minor
1
2016
11
0.030
 Why?
Tissue Array Analysis
1
2016
51
0.030
 Why?
Adenosine Triphosphate
1
2019
498
0.030
 Why?
Health Surveys
1
2018
509
0.030
 Why?
Cell Membrane
1
2020
709
0.030
 Why?
Leukemia, B-Cell
1
2016
13
0.030
 Why?
Neoplasm Invasiveness
1
2018
515
0.030
 Why?
Radiotherapy
1
2017
208
0.030
 Why?
HLA-A1 Antigen
1
2015
4
0.030
 Why?
Fas Ligand Protein
1
2015
61
0.030
 Why?
Antigen-Antibody Reactions
1
2015
49
0.030
 Why?
Palate
1
2016
40
0.030
 Why?
Genes, erbB-2
1
2015
35
0.030
 Why?
MAP Kinase Signaling System
1
2017
316
0.030
 Why?
Anemia
1
2017
180
0.030
 Why?
Salvage Therapy
1
2016
156
0.030
 Why?
Interferon-gamma Release Tests
1
2015
33
0.030
 Why?
Anus Neoplasms
1
2015
33
0.030
 Why?
Compulsive Behavior
1
2015
7
0.030
 Why?
Feasibility Studies
1
2020
1065
0.030
 Why?
Health Promotion
1
2022
765
0.030
 Why?
Machine Learning
1
2021
573
0.030
 Why?
Gastrointestinal Diseases
1
2017
209
0.030
 Why?
Thrombocytopenia
1
2017
208
0.030
 Why?
Necrosis
1
2016
244
0.030
 Why?
Cloning, Molecular
1
2016
543
0.030
 Why?
HIV Envelope Protein gp120
1
2015
61
0.030
 Why?
DNA, Neoplasm
1
2015
165
0.030
 Why?
Coronary Occlusion
1
2015
20
0.030
 Why?
Dermatitis
1
2014
19
0.030
 Why?
HIV Antibodies
1
2015
67
0.030
 Why?
Income
1
2016
197
0.030
 Why?
Regression Analysis
1
2017
1003
0.030
 Why?
Metabolic Clearance Rate
1
2014
116
0.030
 Why?
Protein Conformation
1
2018
933
0.030
 Why?
Desmoplakins
1
2014
27
0.030
 Why?
Monophenol Monooxygenase
1
2014
8
0.030
 Why?
Cell Survival
1
2017
1110
0.030
 Why?
Comparative Genomic Hybridization
1
2014
30
0.030
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2015
152
0.030
 Why?
Nausea
1
2014
111
0.030
 Why?
Mice, Inbred BALB C
1
2017
1270
0.030
 Why?
Gene Library
1
2014
126
0.030
 Why?
Models, Statistical
1
2018
680
0.030
 Why?
Random Allocation
1
2014
364
0.030
 Why?
National Institutes of Health (U.S.)
1
2014
138
0.030
 Why?
MAP Kinase Kinase 4
1
2013
24
0.030
 Why?
Social Class
1
2016
270
0.030
 Why?
Histocompatibility Antigens
1
2014
103
0.030
 Why?
Substrate Specificity
1
2014
379
0.030
 Why?
Infusions, Intravenous
1
2014
427
0.030
 Why?
Graft vs Host Disease
1
2016
265
0.030
 Why?
X-Ray Diffraction
1
2013
104
0.020
 Why?
Lentivirus
1
2013
61
0.020
 Why?
Confidence Intervals
1
2014
330
0.020
 Why?
Tumor Burden
1
2014
321
0.020
 Why?
Radiotherapy, Adjuvant
1
2014
219
0.020
 Why?
Immunoenzyme Techniques
1
2013
200
0.020
 Why?
Sleep Wake Disorders
1
2017
312
0.020
 Why?
Immunoprecipitation
1
2013
152
0.020
 Why?
Structure-Activity Relationship
1
2014
567
0.020
 Why?
Fever
1
2014
311
0.020
 Why?
Bias
1
2013
205
0.020
 Why?
Drug Administration Schedule
1
2014
779
0.020
 Why?
Reproducibility of Results
2
2012
3392
0.020
 Why?
Models, Molecular
1
2018
1600
0.020
 Why?
Cotinine
1
2012
78
0.020
 Why?
Health Services Accessibility
1
2021
1078
0.020
 Why?
Histocompatibility Antigens Class II
1
2014
366
0.020
 Why?
DNA Primers
1
2013
516
0.020
 Why?
Cost-Benefit Analysis
1
1995
616
0.020
 Why?
Receptors, Immunologic
1
2013
207
0.020
 Why?
Spleen
1
2014
517
0.020
 Why?
Bayes Theorem
1
2013
427
0.020
 Why?
Blotting, Western
1
2013
1207
0.020
 Why?
Pregnancy
1
2023
7154
0.020
 Why?
Diagnosis, Differential
1
2015
1502
0.020
 Why?
Multivariate Analysis
1
2014
1508
0.020
 Why?
Carrier Proteins
1
2014
750
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
2030
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2015
1223
0.020
 Why?
Kinetics
1
2013
1622
0.020
 Why?
Phosphorylation
1
2014
1761
0.020
 Why?
Infant, Premature
1
2014
611
0.020
 Why?
North Carolina
1
2008
130
0.020
 Why?
Germany
1
2008
141
0.020
 Why?
Self Report
1
2012
864
0.020
 Why?
Cell Differentiation
1
2015
2045
0.020
 Why?
Vaccination
1
2016
1414
0.020
 Why?
Disease Models, Animal
1
2018
4553
0.020
 Why?
Intelligence
1
2007
117
0.020
 Why?
MicroRNAs
1
2013
699
0.020
 Why?
Models, Biological
1
2014
1833
0.020
 Why?
Polymorphism, Single Nucleotide
1
2013
2167
0.010
 Why?
Receptors, Urokinase Plasminogen Activator
1
2004
11
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2004
26
0.010
 Why?
Transplantation, Heterologous
1
2004
196
0.010
 Why?
Species Specificity
1
2004
573
0.010
 Why?
Neovascularization, Pathologic
1
2004
290
0.010
 Why?
Mice, Nude
1
2004
692
0.010
 Why?
Down Syndrome
1
1987
523
0.010
 Why?
Polyethylene Glycols
1
2004
638
0.010
 Why?
Endothelium, Vascular
1
2004
965
0.010
 Why?
Rosenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (599) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)